In 2009, the European Society of Hypertension (ESH) has developed a document updating the recommendations for the diagnosis and treatment of hypertension issued in 2007. The main elements of novelty refer to the assessment of organ damage, the blood pressure thresholds for treatment initiation as well as the blood pressure goals, the use of drug combination treatment and the therapeutic intervention in specific clinical conditions. This paper will review the novelties of the ESH update document and the implications of the "new guidelines" for current clinical practice. © 2010 Bentham Science Publishers Ltd.

Mancia, G., Grassi, G. (2010). What changes we may expect in 2010 hypertension diagnosis and management: Insights from the European update document. CURRENT VASCULAR PHARMACOLOGY, 8(6), 788-791 [10.2174/157016110793563942].

What changes we may expect in 2010 hypertension diagnosis and management: Insights from the European update document

MANCIA, GIUSEPPE
;
GRASSI, GUIDO
2010

Abstract

In 2009, the European Society of Hypertension (ESH) has developed a document updating the recommendations for the diagnosis and treatment of hypertension issued in 2007. The main elements of novelty refer to the assessment of organ damage, the blood pressure thresholds for treatment initiation as well as the blood pressure goals, the use of drug combination treatment and the therapeutic intervention in specific clinical conditions. This paper will review the novelties of the ESH update document and the implications of the "new guidelines" for current clinical practice. © 2010 Bentham Science Publishers Ltd.
Articolo in rivista - Articolo scientifico
Risk Assessment; Blood Pressure Determination; Treatment Outcome; Prognosis; Practice Guidelines as Topic; Antihypertensive Agents; Drug Therapy, Combination; Hypertension; Drug Combinations; Cardiovascular Diseases; Humans;
English
2010
8
6
788
791
none
Mancia, G., Grassi, G. (2010). What changes we may expect in 2010 hypertension diagnosis and management: Insights from the European update document. CURRENT VASCULAR PHARMACOLOGY, 8(6), 788-791 [10.2174/157016110793563942].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/27057
Citazioni
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 3
Social impact